Dapagliflozin vs Irbesartan

Dapagliflozin vs Irbesartan: Overview

This comparison examines the pharmacological differences between Dapagliflozin and Irbesartan.

Mechanism of Action

Dapagliflozin: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.

Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.

Pharmacokinetics

Half-life: Dapagliflozin — 12.9 hours; Irbesartan — 11-15 hours.

Chemical Properties

Molecular Formula: Dapagliflozin — C21H25ClO6; Irbesartan — C25H28N6O.

Molecular Weight: Dapagliflozin — 408.8730 g/mol; Irbesartan — 428.5320 g/mol.

Type: Dapagliflozin — Small molecule; Irbesartan — Small molecule.